Blair William & Co. IL Has $8.23 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Blair William & Co. IL reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 109,618 shares of the company’s stock after selling 35,503 shares during the quarter. Blair William & Co. IL’s holdings in GE HealthCare Technologies were worth $8,232,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the company. First Trust Advisors LP grew its holdings in GE HealthCare Technologies by 12.4% during the 3rd quarter. First Trust Advisors LP now owns 932,168 shares of the company’s stock worth $70,006,000 after acquiring an additional 102,847 shares during the period. HUB Investment Partners LLC bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth about $219,000. Barclays PLC lifted its stake in shares of GE HealthCare Technologies by 10.4% in the 3rd quarter. Barclays PLC now owns 1,753,314 shares of the company’s stock valued at $131,674,000 after purchasing an additional 164,821 shares during the period. Advisory Alpha LLC acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $265,000. Finally, Viawealth LLC grew its stake in GE HealthCare Technologies by 5.6% during the third quarter. Viawealth LLC now owns 4,669 shares of the company’s stock worth $351,000 after purchasing an additional 246 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Morgan Stanley boosted their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Piper Sandler increased their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Evercore lifted their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Stock Up 1.8%

Shares of NASDAQ:GEHC opened at $75.63 on Tuesday. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The company has a market capitalization of $34.47 billion, a PE ratio of 16.59, a price-to-earnings-growth ratio of 1.63 and a beta of 1.03. The business has a fifty day moving average price of $81.66 and a two-hundred day moving average price of $78.62. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.